Clinical trial finds finerenone reduces worsening heart failure and cardiovascular death
Science Daily: Pharmacology News
SEPTEMBER 2, 2024
Finerenone reduced the composite of total first and recurrent heart failure (HF) events (hospitalizations for HF or urgent HF visits) and cardiovascular death in patients with HF and mildly reduced or preserved ejection fraction, according to an international clinical trial.
Let's personalize your content